ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment.

Yi, Ruibin; Lin, Anqi; Cao, Manming; Xu, Abai; Luo, Peng; Zhang, Jian

Yi, Ruibin; Lin, Anqi; Cao, Manming; Xu, Abai; Luo, Peng; Zhang, Jian.

Afiliação

Yi R; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Lin A; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Cao M; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Xu A; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Luo P; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhang J; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Front Genet ; 11: 933, 2020.

Article em En | MEDLINE | ID: mdl-32922441

Palavras-chave

ATM; DDR; bladder cancer; immune checkpoint inhibitors; tumor microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google